How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,246 results for

Emergency Medicine Treatment and Labor Act

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Shoulder Conditions Diagnosis and Treatment Guideline

-arthroplasty urgently or emergently is reasonable. I. Manipulation under anesthesia/arthroscopic capsular release Manipulation under anesthesia, or arthroscopic capsular release, may be considered if a patient has persistent stiffness, typically after a procedure that has not responded to at least 12 weeks of physical therapy and/or directed home exercises. Washington State Department of Labor and Industries Medical Treatment Guideline for Shoulder Diagnosis and Treatment –updated May 2018 J. Diagnostic (...) and teres minor 6 weeks of physical therapy Note: A steroid injection may be considered prior to physical therapy if no contraindication and clinically appropriate Washington State Department of Labor and Industries Medical Treatment Guideline for Shoulder Diagnosis and Treatment –updated May 2018 A request may be appropriate for If the patient has AND the diagnosis is supported by these clinical findings: AND this has been done Surgical Procedure Diagnosis Subjective Objective Imaging Non-operative

2018 Washington State Department of Labor and Industries

82. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

of phototherapy and infused therapy. Problems with coverage • Requirements for “step therapy” forcing patients to start treatment with less efficacious medications. • Lack of clarity in the exception process and timing for physicians and patients. • Patients have to “start over” with “step therapy” of previously-tried medications after switching insurance. • High out of pocket costs hindering treatment or leading to undertreatment. Potential Cost-Saving Measures in Psoriasis As described in its Final Value (...) of targeted immunomodulator therapy was assessed at the end of the induction period (between 10 and 16 weeks after initiation, depending on agent), after which treatment crossover was typically allowed. Because of this, we could only confidently compare the comparative efficacy of targeted immunomodulators at the end of the induction period. Long-term effectiveness and safety data were variably reported by individual drug. Table ES2. Certolizumab Pegol, Guselkumab, Tildrakizumab and Risankizumab Phase III

2018 California Technology Assessment Forum

83. Preterm Labor (Treatment)

disease. Magnesium sulfate should not be used in conjunction with select medications, such as calcium channel blockers, or when myasthenia gravis or neuromuscular disorders exist. In addition, the US Food and Drug Administration (FDA) has warned against extended magnesium sulfate injections in pregnancy. In 2013, the FDA issued a safety alert advising against the off-label administration of magnesium sulfate injections to pregnant women for more than 5-7 days as a means of stopping preterm labor (...) Preterm Labor (Treatment) Preterm Labor: Practice Essentials, Overview, Risk of Preterm Labor Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMjYwOTk4LW92ZXJ2aWV3 processing > Preterm Labor Updated: Dec 17, 2018

2014 eMedicine.com

84. Management of the Third Stage of Labor (Treatment)

of Obstetrical Emergencies . 3rd ed. Bristol, UK: Clinical Press; 1999. 196-201. Sleep J. Physiology and management of the third stage of labour. Bennett VR, Brown LK, eds. Myles' Textbook for Midwives . 12th ed. London, UK: Churchill Livingstone; 1993. 216-29. Dupont C, Ducloy-Bouthors AS, Huissoud C. [Clinical and pharmacological procedures for the prevention of postpartum haemorrhage in the third stage of labor.]. J Gynecol Obstet Biol Reprod (Paris) . 2014 Nov 6. 43(10):966-997. . Prendiville WJ (...) Management of the Third Stage of Labor (Treatment) Management of the Third Stage of Labor: Overview, Clinical Presentation, Management Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMjc1MzA0LW92ZXJ2aWV3 processing

2014 eMedicine.com

85. Consultation for Simple Laceration Repair When On-Call in the Emergency Department: Potential Quagmire Full Text available with Trip Pro

in the case of a simple laceration; or is it subservient to either the discretion of the requesting health-care provider or even the patient? Do federal statutes such as the Emergency Medical Treatment and Labor Act, or perhaps more local rules apply, such as the by-laws of the hospital? It would behoove all medical practitioners to familiarize themselves with both the legal and moral implications of these issues. Having legitimate policies in place which actively address those situations where (...) Consultation for Simple Laceration Repair When On-Call in the Emergency Department: Potential Quagmire What are the forces obligating a plastic surgeon who is on-call for the emergency department to respond to a consultation request for repair of a simple laceration? Although the duties are clear in cases of obvious surgical emergency, ambiguity and subsequent conflict may arise when the true nature of the emergency is less clear. Does the consultant's clinical discretion dictate the obligation

2017 Plastic and Reconstructive Surgery Global Open

86. Complexities of Consent: Ethics in the Pediatric Emergency Department. (Abstract)

Medical Treatment and Active Labor Act, in emergent situations, consent may not be necessary. Finally, adolescents are often deeply concerned about privacy-their acceptance of appropriate care is often based on this promise of confidentiality. In the emergency department, adolescents can therefore be treated for issues relating to reproductive care without parental consent. It is important for the emergency department physician to understand the rules surrounding the care of pediatric patients (...) autonomy through allowing him or her to be an active part of the decision-making process. Consent in the pediatric emergency department can be a complex process. Parental consent is generally required for medical evaluation and treatment of pediatric patients, but in the pediatric emergency department, there are exceptions to this rule. If the provider determines that a parent's refusal of consent places the child at risk of harm, then consent is not necessary. By using the concepts of Emergency

2017 Pediatric Emergency Care

87. Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

of hypoglycemia. The investigators will compare the efficacy and safety of exenatide alone or in combination with basal insulin to control high blood glucose levels resulting in a lower risk of hypoglycemia. Condition or disease Intervention/treatment Phase Type 2 Diabetes Drug: Exenatide Drug: Glargine Drug: Oral antidiabetic drugs Drug: Rapid-acting insulin analogs Phase 4 Detailed Description: The association between hyperglycemia and poor clinical outcomes in patients with diabetes is well established (...) : None (Open Label) Primary Purpose: Treatment Official Title: Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes Actual Study Start Date : September 2015 Actual Primary Completion Date : March 2018 Actual Study Completion Date : March 2018 Resource links provided by the National Library of Medicine related topics: related topics: available

2015 Clinical Trials

88. Neonatal infection: antibiotics for prevention and treatment

Capacity Act. In Wales, healthcare professionals should follow advice on consent from the Welsh Government. If the woman is under 16, healthcare professionals should follow the Department of Health's guidance in Seeking consent: working with children. Sometimes if a baby appears to have a serious illness that could indicate the need for urgent treatment the medical staff may not have time to fully discuss what is involved in that treatment beforehand. In an emergency, if the person with parental (...) treatment 10 Care setting 11 1 Guidance 12 1.1 Information and support 12 1.2 Risk factors for infection and clinical indicators of possible infection 15 1.3 Intrapartum antibiotics 19 1.4 Avoiding routine use of antibiotics in the baby 19 1.5 Investigations before starting antibiotics in the baby 20 1.6 Antibiotics for suspected infection 21 1.7 Duration of antibiotic treatment 22 1.8 Therapeutic drug monitoring for gentamicin 24 1.9 Care setting 25 2 Notes on the scope of the guidance 27 3

2012 National Institute for Health and Clinical Excellence - Clinical Guidelines

89. Emergency medical technician

"Emergency Medical Technician", or 'EMT', for the Primary Care Paramedic; and 'Paramedic' only for those qualified as Advanced Care Paramedics (ALS) providers. Only someone registered in Alberta can call themselves an EMT or Paramedic in Alberta, the title is legally protected. Almost all other are gradually moving to adopting the new titles, or have at least recognized the NOCP document as a benchmarking document to permit inter-provincial labour mobility of practitioners, regardless of how titles (...) recognized under the National Occupational Competency Profile, although unlike the next three successive levels of practice,The high number of EMRs across Canada cannot be ignored as contributing a critical role in the chain of survival, although it is a level of practice that is least comprehensive (clinically speaking), and is also generally not consistent with any medical acts beyond advanced first-aid and oxygen therapy,administration of ASA and oral glucose and administration of narcan

2012 Wikipedia

90. Late Effects of Treatment for Childhood Cancer (PDQ®): Health Professional Version

of Medicine. A risk-based medical follow-up is recommended, which includes a systematic plan for lifelong screening, surveillance, and prevention that incorporates risk estimates based on the following:[ ] Previous cancer. Cancer therapy. Genetic predisposition. Lifestyle behaviors. Comorbid conditions. Sex. Part of long-term follow-up is also focused on appropriate screening of educational and vocational progress. Specific treatments for childhood cancer, especially those that directly impact nervous (...) Late Effects of Treatment for Childhood Cancer (PDQ®): Health Professional Version Late Effects of Treatment for Childhood Cancer (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer Information

2018 PDQ - NCI's Comprehensive Cancer Database

91. Diagnosis, Staging and Treatment of Patients with Prostate Cancer

cancer The diagnosis, staging and treatment of patients with prostate cancer requires multidisciplinary care in an acute hospital setting. The majority of patients will require diagnostic tests (radiology, pathology) and depending on the treatment plan may require surgery, chemotherapy and radiation therapy. A proportion of patients may also require palliative care. A recent population-based cost analysis (Luengo-Fernandez et al., 2013) illustrated the economic burden of cancer on the European Union (...) , in cancers with costs that can accrue over several years (e.g. prostate cancer). In Ireland, inpatient care costs were estimated to account for €417 million of cancer-related healthcare costs out of a total of €619 million. Drug expenditure accounted for a further €127 million, while primary, outpatient and emergency care were estimated at €32 million, €30 million and €13 million, respectively (Luengo-Fernandez et al., 2013). 1.3 Objectives of the National Clinical Guideline The overall objectives

2016 National Clinical Guidelines (Ireland)

92. Diagnosis and Treatment of Primary Adrenal Insufficiency

of glucocorticoid replacement therapies, with doses adjusted according to individual need. (2|⊕⊕⚪⚪) 3.19 In children with PAI, we suggest avoiding synthetic, long-acting glucocorticoids (eg, prednisolone, dexamethasone). (2|⊕⊕⚪⚪) 3.20 We suggest monitoring glucocorticoid replacement by clinical assessment, including growth velocity, body weight, blood pressure, and energy levels. (Ungraded best practice statement) 3.21 In children with PAI and confirmed aldosterone deficiency, we recommend treatment (...) and adrenal crisis-prevention strategies including parenteral self- or lay-administration of emergency glucocorticoids. (Ungraded best practice statement) 4.5 We recommend that all patients should be equipped with a steroid emergency card and medical alert identification to inform health personnel of the need for increased glucocorticoid doses to avert or treat adrenal crisis and the need of immediate parenteral steroid treatment in the event of an emergency. (Ungraded best practice statement) 4.6 We

2016 The Endocrine Society

93. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

populations 24 4 HEALTH SECTOR INVERVENTIONS 26 4.1 Prevention 26 4.1.1 Comprehensive condom and lubricant programming 26 4.1.2 Harm reduction for people who inject drugs 29 4.1.3 Behavioural interventions 40 4.1.4 Prevention of transmission in health-care settings 43 4.1.5 ARV-related prevention 44 4.1.6 Voluntary medical male circumcision for HIV prevention 48 4.2 HIV testing and counselling 50 4.3 Linkage and enrolment in care 54 4.4 HIV treatment and care 55 4.4.1 Antiretroviral therapy 55 4.4.2 (...) HCV hepatitis C virus HIV human immunodeficiency virus HIVST HIV self-testing HPV human papillomavirus HTC HIV testing and counselling IPT isoniazid preventive treatment LPV/r lopinavir/ritonavir M&E monitoring and evaluation MAT medically assisted treatment MMT methadone maintenance treatment NNRTI non-nucleoside reverse transcriptase inhibitor NSP needle and syringe programme OST opioid substitution therapy PEP post-exposure prophylaxis PEPFAR United States President’s Emergency Plan for AIDS

2016 World Health Organisation HIV Guidelines

94. Diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease

therapy with etoposide and cisplatin. Such patients may also benefit fr om substitution of EMA/CO with EP/EMA (Etoposide and cisplatin plus etoposide, methotrexate, actinomycin D) (Grade C). 2.4.4.1 For women with low-risk GTN undergoing first-line chemotherapy, the first ± second course of chemotherapy should be administered as an in-patient at a centre with medical oncology, gynaecological services and interventional radiology (Grade C). 2.4.5.1 Monitoring during treatment low-risk: Patients should (...) and Advisory Centre will have the potential to identify the volume of patients with GTD in the country, which should inform costs. 1.3 Objectives of the National Clinical Guideline The overall objectives of the National Clinical Guideline No. 13 ‘Diagnosis, staging and treatment of patients with GTD’ are: • To improve the quality of clinical care, • To prevent variation in practice, • To address areas of clinical care with new and emerging evidence, • Based on the best research evidence in conjunction

2015 Health Service Executive (Ireland) - Clinical Guidelines

95. National Clinical Guideline for the Diagnosis, Staging and Treatment of Prostate Cancer

-related healthcare costs out of a total of €619 million. Drug expenditure accounted for a further €127 million, while primary, outpatient and emergency care were estimated at €32 million, €30 million and €13 million, respectively (Luengo-Fernandez et al., 2013). 1.3 Objectives of the National Clinical Guideline The overall objectives of the National Clinical Guideline No. 8 ‘Diagnosis, staging and treatment of patients with prostate cancer’ are: • To improve the quality of clinical care, • T o pr (...) will require diagnostic tests (radiology, pathology) and depending on the treatment plan may require surgery, chemotherapy and radiation therapy. A proportion of patients may also require palliative care. A recent population-based cost analysis (Luengo-Fernandez et al., 2013) illustrated the economic burden of cancer on the European Union (EU). In 2009, cancer is estimated to have cost the EU €126 billion, with healthcare costs accounting for €51 billion (40%). Prostate cancer is estimated to have cost

2015 Health Service Executive (Ireland) - Clinical Guidelines

96. Diagnosis, Staging and Treatment of Patients with Gestational Trophoblastic Disease

therapy with etoposide and cisplatin. Such patients may also benefit fr om substitution of EMA/CO with EP/EMA (Etoposide and cisplatin plus etoposide, methotrexate, actinomycin D) (Grade C). 2.4.4.1 For women with low-risk GTN undergoing first-line chemotherapy, the first ± second course of chemotherapy should be administered as an in-patient at a centre with medical oncology, gynaecological services and interventional radiology (Grade C). 2.4.5.1 Monitoring during treatment low-risk: Patients should (...) and Advisory Centre will have the potential to identify the volume of patients with GTD in the country, which should inform costs. 1.3 Objectives of the National Clinical Guideline The overall objectives of the National Clinical Guideline No. 13 ‘Diagnosis, staging and treatment of patients with GTD’ are: • To improve the quality of clinical care, • To prevent variation in practice, • To address areas of clinical care with new and emerging evidence, • Based on the best research evidence in conjunction

2015 National Clinical Guidelines (Ireland)

97. Treatment of Fecal Incontinence

included “fecal incontinence” anD [“fecal oR anal oR stool”], anD [“physical therapy oR rehabilitation oR biofeedback”], anD [“sphincteroplasty” oR “implants” oR “bowel sphincter” oR “artificial sphincter” oR “ra- diofrequency” oR “sacral nerve stimulation” oR “inject- able”]. Directed searches of the embedded references from The American Society of Colon and Rectal Surgeons’ Clinical Practice Guideline for the Treatment of Fecal Incontinence Ian M. Paquette, M.D.• Madhulika G. Varma, M.D.• Andreas M (...) are based on patients’ subjective experience of fi, and none correlate well with objective parameters and/or coping mechanisms. t here is also no perfect cor- relation between any of the instruments and prediction of outcomes for various management options. n evertheless, the use of these instruments is recom- mended because a validated measure of severity is help- ful in selecting patients for therapies and for measuring response to treatment over time. Patients with more severe symptoms or for whom

2015 American Society of Colon and Rectal Surgeons

98. A cost-effectiveness analysis of maternal genotyping to guide treatment for postpartum pain and avert infant adverse events

not received genetic screening information prior to commencing post-partum codeine therapy. 6 2 Methods This work includes a series of studies culminating in a CEA performed by decision analysis. The initial study involved a medical record review to establish the prevalence of use of various analgesics in the postnatal ward at St. Michael’s hospital in Toronto. This was the site of a clinical study where the proposed intervention of CYP2D6 screening to guide analgesic treatment was conducted. Within (...) quality of life (HRQoL) before and after drug therapy. A patient tracking sheet was used for patients to self-report medication use and infant medical status or adverse event after discharge. Patients were also asked to complete a health service use and cost diary to record health services use throughout the duration of drug therapy and for the duration of any adverse event and its resolution. 10 Figure 2.1: Study procedures 6 weeks prior to delivery 2 weeks prior to delivery 1 day after delivery

2015 SickKids Reports

99. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults Full Text available with Trip Pro

of rhPTH will improve QoL and reduce the risk of complications. In January 2015, the American Food and Drug Administration approved the use of rhPTH(1–84) (Natpara) as a supplement to conventional treatment (FDA 2015: ). The drug is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) and carries a ‘black box warning’ that bone cancer (osteosarcoma) has been observed in rat studies with rhPTH. It is unknown whether long-term therapy also may cause (...) with an increased prevalence in HypoPT. list drugs, conditions and diseases which may interfere with calcium homeostasis. If a patient is diagnosed with one of the diseases or initiates treatment with one of the drugs, this may necessitate changes in the medical treatment of HypoPT in order to maintain normocalcaemia. Table 3 Symptoms patients should be informed to allow for early detection of hypo- or hypercalcaemia. Organ System Hypocalcaemia Hypercalcaemia CNS Depression Weakness Irritability Headache

2015 European Society of Endocrinology

100. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013. These guidelines will be updated in 2015. CHAPTER 7: SECOND-LINE ANTIVIRAL THERAPIES FOR THE MANAGEMENT OF TREATMENT FAILURE • In persons with confirmed or suspected antiviral resistance (i.e. history of prior exposure or primary non-response) to lamivudine, entecavir, adefovir or telbivudine, a switch to tenofovir (...) below which HBV DNA concentrations are indicative of “inactive” disease, or the threshold above which treatment should be initiated (28). HBV DNA concentrations are also used for optimal monitoring of response to antiviral therapy, and a rise may indicate the emergence of resistant variants. WHO standards are now available for expression of HBV DNA concentrations (31,32). Serum HBV DNA levels should be expressed in IU/mL to ensure comparability; values given as copies/mL can be converted to IU/mL

2015 World Health Organisation HIV Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>